Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Implementing Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Internal Medicine Germany Title Grant Type Focus Area Country Application Due Date Research on Long-Acting Growth HormoneRelease Date:Research Rare Disease All Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local LevelRelease Date:Quality Improvement Inflammation & Immunology China Real-World Evidence of SUL-DUR on Special Populations with CRAB InfectionRelease Date:Research Inflammation & Immunology China Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator TherapyRelease Date:Education Inflammation & Immunology USA Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold InfectionsRelease Date:Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patientsRelease Date:Quality Improvement Oncology Spain Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA